Emergency Department (ED) Self-Monitoring Pilot COVID-19

NCT ID: NCT04462783

Last Updated: 2021-07-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2021-06-30

Study Completion Date

2021-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This feasibility study is being conducted to understand how discharged emergency department patients who were tested for the SARS-CoV-2 virus (COVID-19) engage with a symptom-tracking web application. Study participants that are enrolled in the study will be asked to enter daily information about their health into the CovidX web application (app.). In addition, patients will answer questions regarding anxiety levels, use a pulse oximeter to record information (if you own one or are given one).

The investigators predict that participants will be able to engage with the CovidX web application over several days to weeks for the purposes of symptom tracking, and may have decreased anxiety over the study period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID Covid-19 SARS-CoV 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Some patients will have pulse oximeters or be given one and provide data from these.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient's symptom data without pulse oximeter

Some patients may not be given a pulse oximeter to enter heart rate and O2 saturation into the CovidX application.

Group Type EXPERIMENTAL

Symptoms entered into the CovidX application

Intervention Type OTHER

Participants are asked to enter symptoms into the CovidX application at least daily for 30 days. Additionally, they will enter demographic information and some survey information will be collected.

Patient's symptom data with a pulse oximeter

Some patients will be given (or may have) a pulse oximeter in order to enter heart rate and O2 saturation data into the CovidX application.

Group Type EXPERIMENTAL

Symptoms entered into the CovidX application

Intervention Type OTHER

Participants are asked to enter symptoms into the CovidX application at least daily for 30 days. Additionally, they will enter demographic information and some survey information will be collected.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Symptoms entered into the CovidX application

Participants are asked to enter symptoms into the CovidX application at least daily for 30 days. Additionally, they will enter demographic information and some survey information will be collected.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Reported symptoms of viral illness during ED encounter
* Tested for SARS-CoV-2 (COVID-19) during ED encounter
* Discharged home from the Emergency Department

Exclusion Criteria

* Prisoners
* Residents of congregate living facilities who are already being monitored
* Baseline oxygen requirement
* Patients whose primary goals of care are palliative
* Pregnant women
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vironix Health Incorporated

UNKNOWN

Sponsor Role collaborator

University of Michigan

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Kathleen Li

Adjunct Clinical Lecturer in Emergency Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kathleen Li, MD

Role: PRINCIPAL_INVESTIGATOR

University of Michigan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HUM00181946

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

COVID-19 Remote Monitoring
NCT04350476 WITHDRAWN NA
COVID-19 Watch + COVID-19 Pulse
NCT04581863 COMPLETED NA
Pilot Deployment of ePNa Into Epic EHR
NCT06008314 NOT_YET_RECRUITING NA
EEG Detection of Delirium
NCT04797052 COMPLETED NA